180 related items for PubMed ID: 8701396
1. Increased plasma levels of tissue factor pathway inhibitor (TFPI) after n-3 polyunsaturated fatty acids supplementation in patients with chronic atherosclerotic disease.
Berrettini M, Parise P, Ricotta S, Iorio A, Peirone C, Nenci GG.
Thromb Haemost; 1996 Mar; 75(3):395-400. PubMed ID: 8701396
[Abstract] [Full Text] [Related]
2. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
Svensson M, Schmidt EB, Jørgensen KA, Christensen JH.
Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
[Abstract] [Full Text] [Related]
3. Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: a randomized, double-blind, placebo-controlled study.
Thusgaard M, Christensen JH, Mørn B, Andersen TS, Vige R, Arildsen H, Schmidt EB, Nielsen H.
Scand J Infect Dis; 2009 Sep; 41(10):760-6. PubMed ID: 19685375
[Abstract] [Full Text] [Related]
4. [Effect of n-3 polyunsaturated fatty acids on plasma lipid, LDL lipoperoxidation, homocysteine and inflammation indicators in diabetic dyslipidemia treated with statin + fibrate combination].
Zeman M, Zák A, Vecka M, Tvrzická E, Písaríková A, Stanková B.
Cas Lek Cesk; 2005 Sep; 144(11):737-41. PubMed ID: 16335699
[Abstract] [Full Text] [Related]
5. Hypercholesterolaemia alters the responses of the plasma lipid profile and inflammatory markers to supplementation of the diet with n-3 polyunsaturated fatty acids from fish oil.
Bravo E, Napolitano M, Lopez-Soldado I, Valeri M, Botham KM, Stefanutti C.
Eur J Clin Invest; 2006 Nov; 36(11):788-95. PubMed ID: 17032346
[Abstract] [Full Text] [Related]
6. Influence of supplementation with N-3 fatty acids on different coronary risk factors in men--a placebo controlled study.
Deslypere JP.
Verh K Acad Geneeskd Belg; 1992 Nov; 54(3):189-216. PubMed ID: 1413984
[Abstract] [Full Text] [Related]
7. Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study.
Dyerberg J, Eskesen DC, Andersen PW, Astrup A, Buemann B, Christensen JH, Clausen P, Rasmussen BF, Schmidt EB, Tholstrup T, Toft E, Toubro S, Stender S.
Eur J Clin Nutr; 2004 Jul; 58(7):1062-70. PubMed ID: 15220949
[Abstract] [Full Text] [Related]
8. Repeated fasting and refeeding with 20:5, n-3 eicosapentaenoic acid (EPA): a novel approach for rapid fatty acid exchange and its effect on blood pressure, plasma lipids and hemostasis.
Yosefy C, Viskoper JR, Varon D, Ilan Z, Pilpel D, Lugassy G, Schneider R, Savyon N, Adan Y, Raz A.
J Hum Hypertens; 1996 Sep; 10 Suppl 3():S135-9. PubMed ID: 8872845
[Abstract] [Full Text] [Related]
9. N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination.
Zeman M, Zák A, Vecka M, Tvrzická E, Písaríková A, Stanková B.
J Nutr Biochem; 2006 Jun; 17(6):379-84. PubMed ID: 16214329
[Abstract] [Full Text] [Related]
10. Effects of omega-3 fatty acid supplementation on lipid levels in endstage renal disease patients.
Bowden RG, Jitomir J, Wilson RL, Gentile M.
J Ren Nutr; 2009 Jul; 19(4):259-66. PubMed ID: 19539180
[Abstract] [Full Text] [Related]
11. Effects of combined oral hormone replacement therapy on tissue factor pathway inhibitor and factor VII.
Peverill RE, Teede HJ, Smolich JJ, Malan E, Kotsopoulos D, Tipping PG, McGrath BP.
Clin Sci (Lond); 2001 Jul; 101(1):93-9. PubMed ID: 11410120
[Abstract] [Full Text] [Related]
12. n -- 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids.
Barden AE, Dunstan JA, Beilin LJ, Prescott SL, Mori TA.
Clin Sci (Lond); 2006 Oct; 111(4):289-94. PubMed ID: 16822237
[Abstract] [Full Text] [Related]
13. The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure.
Madsen T, Schmidt EB, Christensen JH.
J Ren Nutr; 2007 Jul; 17(4):258-63. PubMed ID: 17586424
[Abstract] [Full Text] [Related]
14. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C.
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[Abstract] [Full Text] [Related]
15. Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects.
Goyens PL, Mensink RP.
Eur J Clin Nutr; 2006 Aug; 60(8):978-84. PubMed ID: 16482073
[Abstract] [Full Text] [Related]
16. Effects of oleic-rich and omega-3-rich diets on serum lipid pattern and lipid oxidation in mildly hypercholesterolemic patients.
Puiggrós C, Chacón P, Armadans LI, Clapés J, Planas M.
Clin Nutr; 2002 Feb; 21(1):79-87. PubMed ID: 11884017
[Abstract] [Full Text] [Related]
17. Consumption of an n-3 polyunsaturated fatty acid-enriched dip modulates plasma lipid profile in subjects with diabetes type II.
Garg ML, Blake RJ, Clayton E, Munro IA, Macdonald-Wicks L, Singh H, Moughan PJ.
Eur J Clin Nutr; 2007 Nov; 61(11):1312-7. PubMed ID: 17299483
[Abstract] [Full Text] [Related]
18. Reduction of blood pressure and plasma triglycerides by omega-3 fatty acids in treated hypertensives.
Lungershausen YK, Abbey M, Nestel PJ, Howe PR.
J Hypertens; 1994 Sep; 12(9):1041-5. PubMed ID: 7852747
[Abstract] [Full Text] [Related]
19. Consumption of n-3 polyunsaturated fatty acid-enriched eggs and changes in plasma lipids of human subjects.
Jiang Z, Sim JS.
Nutrition; 1993 Sep; 9(6):513-8. PubMed ID: 7906572
[Abstract] [Full Text] [Related]
20. Effect of n-3 fatty acids on carotid atherosclerosis and haemostasis in patients with combined hyperlipoproteinemia: a double-blind pilot study in primary prevention.
Baldassarre D, Amato M, Eligini S, Barbieri SS, Mussoni L, Frigerio B, Kozàkovà M, Tremoli E, Sirtori CR, Colli S.
Ann Med; 2006 Sep; 38(5):367-75. PubMed ID: 16938806
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
